BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3890058)

  • 1. Magnetic resonance spectroscopy for evaluation of renal function.
    Weiner MW; Adam WR
    Semin Urol; 1985 Feb; 3(1):34-42. PubMed ID: 3890058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [31-phosphorus magnetic resonance spectroscopy--a new research instrument in urology. Determination of current status and outlook for clinical use].
    Pomer S
    Urologe A; 1989 Jul; 28(4):223-30. PubMed ID: 2669305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines.
    Bretan PN; Vigneron DB; Hricak H; Price DC; Yen TS; Luo JA; Tanagho EA; James TL
    Am Surg; 1993 Mar; 59(3):182-7. PubMed ID: 8386489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of phosphorus nuclear magnetic resonance to problems of renal physiology and metabolism.
    Wong GG; Ross BD
    Miner Electrolyte Metab; 1983; 9(4-6):282-9. PubMed ID: 6656708
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS).
    Bretan PN; Baldwin N; Novick AC; Ng TC; Majors A; Stowe N; Streem S; Steinmuller D; Go R; Meaney T
    Transplant Proc; 1988 Oct; 20(5):852-3. PubMed ID: 3055516
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy in focal epilepsy: 31P and 1H spectroscopy.
    Kuzniecky R
    Rev Neurol (Paris); 1999 Jul; 155(6-7):495-8. PubMed ID: 10472666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus-31 MRS of the kidney.
    Hricak H
    Invest Radiol; 1989 Dec; 24(12):993-6. PubMed ID: 2691445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in 40 recipient patients.
    Bretan PN; Baldwin N; Novick AC; Majors A; Easley K; Ng TC; Stowe N; Streem S; Steinmuller D; Rehm P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1266-7. PubMed ID: 2652418
    [No Abstract]   [Full Text] [Related]  

  • 9. [Magnetic resonance, a means for anatomically reliable imaging and noninvasive metabolic studies of kidney transplants].
    Pomer S; Hull WE; Fichtner K; Möhring K; Staehler G
    Helv Chir Acta; 1992 Oct; 59(3):465-6. PubMed ID: 1464542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy of the heart.
    Schaefer S; Massie B; Weiner MW
    Cardiol Clin; 1989 Aug; 7(3):697-712. PubMed ID: 2670234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR spectroscopy in clinical research.
    Henriksen O
    Acta Radiol; 1994 Mar; 35(2):96-116. PubMed ID: 8172753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cardiac 31P magnetic resonance spectroscopy: reviewing NMR principles.
    Hoffenberg EF; Kozlowski P; Salerno TA; Deslauriers R
    J Surg Res; 1996 Apr; 62(1):135-43. PubMed ID: 8606501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
    Kemp GJ; Meyerspeer M; Moser E
    NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain changes to hypocapnia using rapidly interleaved phosphorus-proton magnetic resonance spectroscopy at 4 T.
    Friedman SD; Jensen JE; Frederick BB; Artru AA; Renshaw PF; Dager SR
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):646-53. PubMed ID: 16896347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skeletal muscle abnormalities in chronic obstructive lung disease with respiratory insufficiency. Value of P31 magnetic resonance spectroscopy].
    Lévy P; Wuyam B; Pépin JL; Reutenauer H; Payen JF
    Rev Mal Respir; 1997 Jun; 14(3):183-91. PubMed ID: 9411595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
    Arnold DL; Taylor DJ; Radda GK
    Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo phosphorus-31 nuclear magnetic resonance study of the regional metabolic response to cardiac ischemia.
    Malloy CR; Matthews PM; Smith MB; Radda GK
    Adv Myocardiol; 1985; 6():461-4. PubMed ID: 3992043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy of ischemic heart disease.
    Sardanelli F; Zandrino F; Molinari G; Cordone S; Delfino L; Levrero F
    Rays; 1999; 24(1):149-64. PubMed ID: 10358392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance studies of epithelial metabolism and function.
    Balaban RS
    Fed Proc; 1982 Jan; 41(1):42-7. PubMed ID: 7035223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.